DK139191D0 - Anvendelse af et n-acylcystein og middel indeholdende et n-acylcystein - Google Patents

Anvendelse af et n-acylcystein og middel indeholdende et n-acylcystein

Info

Publication number
DK139191D0
DK139191D0 DK911391A DK139191A DK139191D0 DK 139191 D0 DK139191 D0 DK 139191D0 DK 911391 A DK911391 A DK 911391A DK 139191 A DK139191 A DK 139191A DK 139191 D0 DK139191 D0 DK 139191D0
Authority
DK
Denmark
Prior art keywords
cystein
acyl
medicinal containing
medicinal
acyl cystein
Prior art date
Application number
DK911391A
Other languages
Danish (da)
English (en)
Other versions
DK139191A (da
Inventor
Wulf Droge
Leonard A Herzenberg
Leonore A Herzenberg
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of DK139191A publication Critical patent/DK139191A/da
Publication of DK139191D0 publication Critical patent/DK139191D0/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK911391A 1989-01-26 1991-07-25 Anvendelse af et n-acylcystein og middel indeholdende et n-acylcystein DK139191D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30239689A 1989-01-26 1989-01-26
PCT/US1990/000363 WO1990008540A1 (en) 1989-01-26 1990-01-24 Treatment of disease associated with hiv-infections

Publications (2)

Publication Number Publication Date
DK139191A DK139191A (da) 1991-07-25
DK139191D0 true DK139191D0 (da) 1991-07-25

Family

ID=23167578

Family Applications (1)

Application Number Title Priority Date Filing Date
DK911391A DK139191D0 (da) 1989-01-26 1991-07-25 Anvendelse af et n-acylcystein og middel indeholdende et n-acylcystein

Country Status (25)

Country Link
US (1) US5607974A (ja)
JP (1) JPH04504570A (ja)
KR (1) KR940002820B1 (ja)
AU (1) AU639686B2 (ja)
BE (1) BE1004168A3 (ja)
CA (3) CA1339256C (ja)
CH (1) CH683499A5 (ja)
DE (1) DE4090165T (ja)
DK (1) DK139191D0 (ja)
FR (1) FR2643557B1 (ja)
GB (1) GB2243296B (ja)
GR (1) GR900100048A (ja)
IE (1) IE62795B1 (ja)
IL (1) IL93162A (ja)
IT (1) IT1237999B (ja)
LU (1) LU87977A1 (ja)
MA (1) MA21739A1 (ja)
MX (1) MX173567B (ja)
NL (1) NL9020094A (ja)
OA (1) OA09503A (ja)
PT (1) PT92949B (ja)
SE (1) SE9101815D0 (ja)
TN (1) TNSN90009A1 (ja)
WO (1) WO1990008540A1 (ja)
ZA (1) ZA90245B (ja)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT100914A (pt) * 1991-09-30 1993-10-29 Jess G Thoene Uso de compostos capazes de sofrer uma permuta mista com dissulfureto, com uma ligacao dissulfureto, no tratamento de infeccao por hiv
US5554655A (en) * 1991-09-30 1996-09-10 Jess G. Thoene Method of treating HIV infection
EP0600462A1 (en) * 1992-12-01 1994-06-08 Nippon Flour Mills Co., Ltd. Reverse transcriptase inhibitors and antiviral agents
AU6060694A (en) * 1993-05-10 1994-11-17 Transcend Therapeutics, Inc Method for treating acquired immune deficiency syndrome
DE4325547C2 (de) * 1993-07-29 1997-11-27 Max Planck Gesellschaft Verwendung von Thiolverbindungen zur Therapie von Hepatitis-_Viren-induzierten Erkrankungen
US5725870A (en) * 1993-10-15 1998-03-10 Thoene; Jess G. Methods, composites and articles for contraception
AU7931094A (en) * 1993-10-15 1995-05-04 Jess G. Thoene Prevention of hiv infection
US5786152A (en) * 1996-04-26 1998-07-28 Amgen Inc. Methods of inhibiting syp binding to a CTLA-4 receptor
HUP9602024A3 (en) * 1996-07-25 1999-05-28 Toth Sandor Pharmaceutical composition containing aminoacid for external use
TW517089B (en) * 1996-09-03 2003-01-11 Res Dev Foundation Assessment of intracellular cysteine and glutathione concentrations
CA2277911C (en) * 1997-01-13 2010-09-14 Emory University Compounds and their combinations for the treatment of influenza infection
US6331610B1 (en) * 1997-04-25 2001-12-18 Metatron, Inc. Method for treating AIDS and HIV infection using select peptides from the beta subunit of human chorionic gonadotropin
US6020205A (en) * 1998-04-10 2000-02-01 Immunosciences Lab, Inc. Determination of intracellular antioxidant levels
US6251868B1 (en) * 1998-04-30 2001-06-26 Teijin Limited Method for treating a human immunodeficiency virus infection
US6566401B2 (en) * 2001-03-30 2003-05-20 The Board Of Trustees Of The Leland Stanford Junior University N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
US6355682B1 (en) * 2001-05-11 2002-03-12 Assa Weinberg Treatment of acute renal failure by administration of N-acetylcysteine
ITMI20011863A1 (it) * 2001-09-05 2003-03-05 Zambon Spa Associazione di farmaci contro il virus dell'influenza
US20050070607A1 (en) * 2003-08-19 2005-03-31 James Andrus N-acetylcysteine compositions and methods for the treatment and prevention of cysteine/glutathione deficiency in diseases and conditions
EP2397189B1 (en) 2003-11-14 2015-03-18 Brigham and Women's Hospital, Inc. Methods of modulating immunity
ITMI20032528A1 (it) * 2003-12-19 2005-06-20 Francesco Santangelo Uso di cistina o di cisteina per la prevenzione e il
US20070053970A1 (en) * 2005-05-25 2007-03-08 Guilford F T Liposomal formulation for oral administration of glutathione (reduced) and/or methylcobalamine for diseases related to glutathione deficiency and deficiency of the methionine remethylation pathway

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4148885A (en) * 1973-09-25 1979-04-10 Institut Merieux Immunostimulant medicine
FR2408387A2 (fr) * 1975-06-30 1979-06-08 Oreal Compositions a base de dispersions aqueuses de spherules lipidiques
US4440788A (en) * 1980-05-13 1984-04-03 Mitsubishi Chemical Industries, Limited Cysteine derivatives
US4335210A (en) * 1981-02-11 1982-06-15 Cornell Research Foundation Method of producing L-cysteine
US4665082A (en) * 1981-02-11 1987-05-12 Cornell Research Foundation Cysteine delivery system
US4438124A (en) * 1981-02-11 1984-03-20 Cornell Research Foundation, Inc. Cysteine delivery system
US4647571A (en) * 1981-02-11 1987-03-03 Cornell Research Foundation Cysteine delivery composition
US4434158A (en) * 1981-02-11 1984-02-28 Cornell Research Foundation Cysteine delivery system
US4879370A (en) * 1983-12-02 1989-11-07 Cornell Research Foundation, Inc. Glutathione delivery system
US4767785A (en) * 1984-01-18 1988-08-30 Michael Georgieff Hypocaloric preparation and intravenous method for hypocaloric treatment of patients
US4744989A (en) * 1984-02-08 1988-05-17 E. R. Squibb & Sons, Inc. Method of preparing liposomes and products produced thereby
EP0158487B1 (en) * 1984-04-09 1991-08-28 Takeda Chemical Industries, Ltd. Stable composition of interleukin-2
US4789633A (en) * 1984-04-19 1988-12-06 University Of Tennessee Research Corporation Fused liposome and acid induced method for liposome fusion
US4710489A (en) * 1985-04-22 1987-12-01 Cornell Research Foundation, Inc. Glutathione delivery system
US4758551A (en) * 1986-07-08 1988-07-19 Cornell Research Foundation, Inc. Methods for combatting renal toxicity due to metals or nephrotoxic drugs and for selectively modulating in vivo formation of leukotriene types
DE3707127C2 (de) * 1987-03-05 1996-06-20 Zambon Spa Verwendung von Methionin zur Behandlung von Immun-Schwächeerkrankungen bei Virusinfektionen und/oder bei Tumorerkrankungen
DE3812008A1 (de) * 1987-04-10 1988-10-20 Pfrimmer Pharma Verwendung von l-(-)-thiazolidin-4-carbonsaeure als cysteinquelle bei gestoerter cysteinsynthese
US4895716A (en) * 1987-06-09 1990-01-23 Biogen, Inc. Stabilized formulations of gamma interferons
DE3906671A1 (de) * 1989-03-02 1990-09-06 Wulf Prof Dr Droege Orales, magenvertraegliches n-acetylcysteinpraeparat hoher dosierung

Also Published As

Publication number Publication date
CA1339070C (en) 1997-07-29
SE9101815L (sv) 1991-06-13
IT9019141A1 (it) 1991-07-24
US5607974A (en) 1997-03-04
LU87977A1 (fr) 1992-03-11
JPH04504570A (ja) 1992-08-13
IE62795B1 (en) 1995-03-08
NL9020094A (nl) 1991-10-01
IT9019141A0 (it) 1990-01-24
CA2045180A1 (en) 1990-07-27
IT1237999B (it) 1993-06-21
KR940002820B1 (ko) 1994-04-04
CA1339256C (en) 1997-08-12
IE900073L (en) 1990-07-26
AU4969490A (en) 1990-08-24
DK139191A (da) 1991-07-25
TNSN90009A1 (fr) 1991-03-05
IL93162A (en) 1995-03-15
WO1990008540A1 (en) 1990-08-09
IL93162A0 (en) 1990-11-05
FR2643557B1 (fr) 1995-02-03
BE1004168A3 (fr) 1992-10-06
GB9112420D0 (en) 1991-07-31
GR900100048A (el) 1991-06-07
MX173567B (es) 1994-03-16
AU639686B2 (en) 1993-08-05
PT92949A (pt) 1990-07-31
GB2243296B (en) 1992-10-21
GB2243296A (en) 1991-10-30
OA09503A (en) 1992-11-15
KR910700045A (ko) 1991-03-13
ZA90245B (en) 1990-10-31
MA21739A1 (fr) 1990-10-01
SE9101815D0 (sv) 1991-06-13
PT92949B (pt) 1995-12-29
DE4090165T (ja) 1991-11-21
FR2643557A1 (fr) 1990-08-31
CH683499A5 (it) 1994-03-31

Similar Documents

Publication Publication Date Title
DK139191D0 (da) Anvendelse af et n-acylcystein og middel indeholdende et n-acylcystein
DK33287A (da) Imidazolanaloge af mevalonolacton og derivater deraf
DK350489D0 (da) Elektrisk resonator og anvendelse af resonator
DK0445255T3 (da) Behandling af tilstande og sygdom
DK170187A (da) Pharmaceutisk fordelagtigt salt af amlodipin og farmaceutiske praeparater indeholdende dette
DK335389A (da) Komposit-agrotekstil og anvendelser af dette
KR890700208A (ko) 카메라 및 다른 기구 지지대
DK433786A (da) Farmaceutiske praeparater og medicinske anvendelser af dioxopiperidinderivater
DK0517761T3 (da) Lipaseholdig flydende pre-spotter og anvendelsen af en sådan pre-spotter
DK323986D0 (da) Diazinylpiperidinderivater af cykliske amider og imider
DK141090D0 (da) Fremstilling af human prourokinase
DK102389D0 (da) Anvendelse af interleukin
DK104389A (da) Anvendelse af imidazolderivater
DK240689A (da) Tinholdige copolymerisater og anvendelse deraf
DK641289A (da) Ophthalmologisk praeparat indeholdende et angiotensin-konverterende anzym og carboanhydrase
DK127187D0 (da) Farmaceutisk kombination af t-pa og oxypurinol
DK299889A (da) Kloning og ekspression af human vaevsfaktor
DK75691A (da) Ny farmaceutisk anvendelse af fusidin og derivater deraf
DK423789D0 (da) Ekspression og anvendelse af et humant plasmaglycoprotein
DK394488D0 (da) 5-pyrimidincarboxamider og behandling af leukaemi dermed
DK394388D0 (da) 5-pyrimidincarboxamider og behandling af leukaemi dermed
BR8903829A (pt) Purificacao de telomeros preparados de cloro-tri-fluor-etileno e tri-cloro-tri-fluor-etano
DK363786A (da) Hydroquinoliner og anvendelse deraf
DK573487D0 (da) Cyklodextrinclathrater af carbacyklinderivater og anvendelse deraf som laegemiddel
DK29687D0 (da) Antihypoxisk medikament med cerebro og hepatobeskyttende virkning og anvendelse af samme

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment